Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 6 EP applications Rachel Margaret Bullett has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11848160

COMPOSITIONS AND METHODS FOR SPINE FUSION PROCEDURES

IPC classification:
A61B 17/58
Agent:
Lavoix Munich
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11799567

TISSUE ENGINEERED BLOOD VESSELS

IPC classification:
A61L 27/50, A61L 27/38, A61L 27/36, A61L 27/18
Applicant:
Cordis Corporation
Agent:
Thomas Prock, Marks & Clerk
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12729758

MCAM ANTAGONISTS AND METHODS OF TREATMENT

IPC classification:
C07K 16/30
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13163291

Treatment of pluripotent cells

IPC classification:
C12N 5/0735
Applicant:
Janssen Biotech, Inc.
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13155730

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

IPC classification:
C12N 5/071, C12N 5/07
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12700043

TUMOUR CELL AND TISSUE CULTURE

IPC classification:
G01N 33/50, C12N 5/09
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature